Inactive Instrument
Protide Pharmaceuticals, Inc. Stock
Stocks
PPMD
US74371A1034
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +83.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CEO | Chief Executive Officer | 70 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CHM | Chairman | 70 | 18/02/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +83.33% | +46.67% | - | - | 886K | |
| +0.88% | +1.18% | +40.64% | +74.91% | 64.69B | |
| -0.26% | +6.91% | +9.79% | +77.36% | 54.78B | |
| +0.47% | +3.52% | +9.71% | +100.95% | 53.49B | |
| -2.43% | +2.96% | +25.90% | +48.44% | 45.98B | |
| -1.76% | +0.18% | +17.57% | +123.61% | 42.94B | |
| -2.36% | +0.97% | +217.17% | +823.78% | 40.08B | |
| -2.26% | -2.06% | +15.38% | +45.14% | 33.52B | |
| +0.22% | -4.77% | +26.59% | +0.55% | 23.97B | |
| +12.10% | +16.60% | +58.50% | +46.15% | 23.67B | |
| Average | +8.79% | +2.22% | +46.81% | +148.99% | 42.57B | |
| Weighted average by Cap. | +0.00% | +2.59% | +44.04% | +150.49% |
Employees
3
